NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.89
-0.12 (-1.20%)
At close: Feb 20, 2026, 4:00 PM EST
10.08
+0.19 (1.92%)
After-hours: Feb 20, 2026, 7:04 PM EST
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$290,933
Profits / Employee
-$43,210
Market Cap
1.28B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | 300 | 13.64% |
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 2,997 |
| Neogen | 2,974 |
| Fulgent Genetics | 1,313 |
| GeneDx Holdings | 1,000 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
| Veracyte | 824 |
| Castle Biosciences | 823 |
NEO News
- 3 days ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 4 days ago - NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - NeoGenomics Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 9 days ago - NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection - Business Wire
- 25 days ago - NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - Business Wire
- 27 days ago - NeoGenomics: Distribution Moat In Community Oncology - Seeking Alpha
- 5 weeks ago - NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue - Business Wire